Abstract: Systems, computer-implemented methods, and computer program products to facilitate sparse depth completion with semantic mesh deformation optimization in an augmented reality environment are provided. According to an embodiment, a system can comprise a processor that executes computer executable components stored in memory. The computer executable components comprise a depth completion component that generates a first depth map from an image and sparse depth samples. The computer executable components further comprise a semantic mesh deformation component that performs a semantic mesh deformation process, using the sparse depth samples, to generate a second depth map comprising a defined image accuracy.

Abstract: The present invention relates to a bromodomain inhibitor. Provided are a compound represented by general formula I or a pharmaceutically acceptable salt, enantiomer, diastereomer, atropisomer, racemate, polymorph, solvate, or isotopically labeled compound (including deuterium substitution) thereof, a preparation method of the same, a pharmaceutical composition comprising the same, and a pharmaceutical use thereof.

Abstract: The present disclosure discloses a control method for a multi-split air conditioning system and a multi-split air-conditioning system, the multi-split air conditioning system, including a compressor and a plurality of indoor units respectively arranged on a plurality of parallel branches, the indoor unit including a fan and the control method including: in a cooling mode, when the multi-split air conditioning system needs oil return, the multi-split air conditioning system opening a branch where an indoor unit in an off state is located, determining whether the indoor unit has reached a dewing condition, opening the branch on which the indoor unit is located, and controlling the fan of the indoor unit according to a determination result.

Abstract: The present disclosure provides use of fructose in preparing a drug for treating a cerebral ischemic stroke, and relates to the technical field of biomedicine. In the present disclosure, an ischemic injury cell model and an ischemic injury animal model are established, and fructose treatment is conducted on the injury models; and it is found that the fructose can regulate energy metabolism and redox metabolism of neurons, and reduce an ischemic injury of model cells and model animals. Specifically, the present disclosure includes: reducing a neuronal mortality after the ischemic injury, reducing an area of cerebral infarction in animals with the ischemic injury, and improving neurobehavioral characteristics of the animals.

Abstract: A query processing method includes decomposing an SQL into logical plans based on data source feature information, to obtain a logical plan set, where the data source feature information is stored in an internal data source feature library of a query engine, and the internal data source feature library is stored in cache space of the query engine; generating physical plans for the logical plan set based on the data source feature information, to obtain a physical plan set; determining query costs of the physical plan set based on the data source feature information, to obtain a physical plan with a highest priority; and executing the physical plan with the highest priority, to obtain a query result queried by a user. A data source registration method and a query engine is further disclosed.

Abstract: Systems, computer-implemented methods, and computer program products to facilitate automatic multi-dimensional model generation and tracking in an augmented reality environment are provided. According to an embodiment, a system can comprise a processor that executes computer executable components stored in memory. The computer executable components comprise a label component that annotates a multi-dimensional point cloud representation of an object present in augmented reality data. The computer executable components further comprise a content generation component that generates a multi-dimensional model of a component of the object based on the multi-dimensional point cloud representation.

Abstract: It is related to compounds used as autophagy modulators and a method for preparing and using the same, specifically providing a compound of general formula (I), or pharmaceutically acceptable salts thereof, which is a type of autophagy modulators, particularly mammalian ATG8 homologues modulators.

Abstract: A method of forming articles from acrylonitrile-butadiene-styrene, the method comprising: feeding a monomer stream comprising a petrochemical monomer into a reactor; contacting the petrochemical monomer with a polymerization activator within the reactor to produce a polymerized stream comprising rubber, latex, or a combination thereof and withdrawing the polymerized stream from the reactor; passing the polymerized stream through a filter to produce a filtered product stream, wherein the filter is a continuously self-cleaning filter; passing the filtered product stream through a grafting unit comprising acrylonitrile and styrene to produce acrylonitrile-butadiene-styrene; and forming an article from the acrylonitrile-butadiene-styrene, wherein the article is an extruded sheet, a molded part, or a combination thereof.

Abstract: A thermoplastic composition includes: a thermoplastic polymer including from about 30 wt % to about 90 wt % poly(methyl methacrylate) (PMMA) and from about 5 wt % to about 70 wt % of a poly(carbonate-siloxane) copolymer having a siloxane content of from about 20 wt % to about 60 wt %; and a plurality of photoluminescent materials including quantum dots.

Abstract: An air conditioning system, comprising an outdoor unit (1) and an indoor heat exchange mechanism (2). The indoor heat exchange mechanism (2) comprises an air conditioner indoor unit (21) and a first heat exchange mechanism (3) used for at least one among water cooling, water heating and space heating. The present air conditioning system integrates various functions into one, such as air-conditioning refrigeration, air-conditioning heating, producing household cold water, producing household hot water, and home heating by means of connecting indoor units for cooling and heating, a water cooling mechanism, a water heating mechanism and a device for floor heating located indoors to one outdoor unit, thereby conserving space and facilitating installation. Moreover, the system directly utilizes high-temperature refrigerant to heat water for floor heating, which replaces coal heating and boiler heating, conserves energy and is environmentally friendly to a greater degree, and improves the living environment.

Abstract: A computer system, non-transitory computer storage medium, and a computer-implemented method of assessing technical risk using visual pattern recognition in an Information Technology (IT) Service Management System. A data visualization engine and a time series generation engine receive the operational data, respectively. A first representation of the data is generated by the data visualization engine, and a second representation of the data is generated by the time series generation engine. Anomaly patterns are identified by a pattern recognition engine configured to perform feature extraction and data transformation. An ensembler is configured to accept the outputs from two AI anomaly engines and make a final decision of whether anomaly patterns are captured. Risk scores based on the identified anomaly patterns are output by a pattern recognition engine to an automated management system. The anomalies includes information regarding vulnerabilities of devices or components of the IT Service Management System.

Abstract: Disclosed is a histone acetyltransferase (HAT) inhibitor. Provided are a compound represented by the general formula I, a pharmaceutically acceptable salt, a stereoisomer, an enantiomer, a diastereoisomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method therefor, a pharmaceutical composition comprising same and use thereof in the treatment of various HAT-related diseases or conditions.

Abstract: Provided are quantum dot film compositions, the compositions comprising a population of quantum dots bearing a passivation layer, the population of quantum dots being disposed in a matrix material. Also provided are methods of forming such compositions and devices that utilize such devices.

Abstract: A thermoplastic composition includes from about 30 wt % to about 95 wt % poly(methyl methacrylate) (PMMA), and from about 5 wt % to about 70 wt % of a poly(carbonate-siloxane) copolymer having a siloxane content of from about 25 wt % to about 45 wt %. A method of making a thermoplastic composition includes: (a) combining from about 30 wt % to about 95 wt % poly(methyl methacrylate) (PMMA) and from about 5 wt % to about 70 wt % of a poly(carbonate-siloxane) copolymer having a siloxane content of from about 25 wt % to about 45 wt % to form a mixture; and melt processing the mixture to polymerize it and form the thermoplastic composition.

Abstract: Thermoplastic compositions include: (a) from about 30 wt % to about 95 wt % poly(methyl methacrylate) (PMMA); and (b) from about 5 wt % to about 70 wt % of a poly(carbonate-siloxane) copolymer having a siloxane content of from about 25 wt % to about 45 wt %. Methods for making a molded article, include: (a) combining from about 30 wt % to about 95 wt % PMMA and from about 5 wt % to about 70 wt % of a poly(carbonate-siloxane) copolymer having a siloxane content of from about 25 wt % to about 45 wt % to form a blend; (b) melt processing and pelletizing the blend; and (c) injection molding the article from the melt processed and pelletized blend.

Abstract: A thermoplastic composition comprising: a polymer material; and a passivated inorganic chromophore comprising an inorganic chromophore and a passivation layer, wherein the inorganic chromophore has the formula: AM1-xM?xM?yO3+y, wherein A, M, M?, M?, x, and y are as provided herein, and wherein the passivation layer is derived from a passivation material comprising a polysiloxane having at least one functional group that is hydride, hydroxy, alkoxy, aryloxy, epoxy, carboxy, amino, or a combination thereof.

Abstract: The present disclosure provides compounds represented by Formula I-A: A1-L1-B1 I-A and the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein A1, B1, and L1 are as defined as set forth in the specification. The present disclosure also provides compounds of Formula I-A for use to treat a condition or disorder responsive to degradation of MDM2 protein such as cancer.

Abstract: The present invention relates to a heterocyclic amide inhibiting RIP1 kinase and the use thereof, and specifically, to a compound of formula I, its pharmaceutically acceptable salts, stereoisomers, enantiomers, diastereomers, atropisomers, optical isomers, racemates, polymorphs, solvates or isotopically labeled compounds, a pharmaceutical composition comprising the compound, and the pharmaceutical use thereof. The compound is particularly effective for treatment of diseases or disorders mediated by RIP1 kinase.